About Us

Prostate cancer

Urothelial cancer

Epidemiology

Functional Urology

Andrology

Pediatric urology

People

Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.

Collaborations

The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

Upcoming Events

The Department of Urology is placed in the Staff Tower (Na buidling), the Erasmus MC Cancer Institute (Be building) and in the research tower (Ee building). The Department Chair is Dr. Joost L. Boormans.

Latest news

Doel Maak kanker Kansloos 2022: Voorspellen van reactie op BCG blaasspoelingen

Dr. T.C.M. Zuiverloon, uroloog Erasmus MC en drs. F.C. de Jong, arts onderzoeker afdeling urologie Erasmus MC leggen uit waar...
Read More

Old timers team lopen blaaskanker kansloos

Heeft u zich al opgegeven voor Maak Kanker Kansloos? Inschrijven en doneren kan via de volgende link: Maak Kanker Kansloos...
Read More

Capture the unseen: Dissertation of Henk Luiting

Dissertation at ErasmusMC department of Urology on May 25th 2022 on the role of MRI and PSAD to omit prostate...
Read More

Studie naar betere behandeling voor blaaskankerpatiënten

‘IMPASSE-studie zoekt uit waarom sommige patiënten niet reageren op bestaande therapie’ Uroloog dr. Tahlita Zuiverloon en onderzoeker dr. Tokameh Mahmoudi...
Read More

New publication: NeuroSAFE in radical prostatectomy increases nerve-sparing surgery without affecting oncological outcome

Abstract Objectives: To investigate the impact of intraoperative neurovascular structure-adjacent frozen-section examination (NeuroSAFE) on nerve-sparing surgery (NSS) and oncological outcome in...
Read More

New publication: Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study

Abstract Background: Urinary incontinence is a prevalent form of pelvic floor dysfunction, with a non-negligible impact on a patient's quality of...
Read More

Blaaskanker Awareness Maand

Blaaskanker bij vrouwen te vaak niet herkend Vrouwen met blaaskanker komen te vaak in een laat stadium bij de specialist...
Read More

Zwem of ren voor blaaskanker

Run4Daniel en Swim4Daniel Het Daniel den Hoed Fonds organiseert in het weekend van 2 & 3 juli 2022 twee sportieve...
Read More

New publication: Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients

Abstract Objectives: To determine the association between the FGFR3 mutation status and immuno-histochemistry (IHC) markers (p53 and Ki-67) in invasive bladder...
Read More

New publication: A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study

Abstract  Background: There is ongoing discussion whether a multivariable approach including magnetic resonance imaging (MRI) can safely prevent unnecessary protocol-advised repeat...
Read More

Update COMPaRE trial

De onderzoeksgroep van de functionele urologie voert een onderzoek uit naar herbruikbare katheters bij mensen die zelf-katheteriseren. Het doel van...
Read More

New publication: Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling

Abstract  Introduction: Castration-resistant prostate cancer (CRPC) remains dependent on androgen receptor (AR) signalling, which is largely driven by conversion of adrenal...
Read More

Abstract presentation at the Society of Pediatric Urology

Pediatric urologist Fred van der Toorn presented an abstract at the Society of Pediatric Urology. The abstract can be found...
Read More

Het Drost-e effect: Dissertation of Frank Jan Drost 

In this video Frank Jan Drost explained how many unnecessary biopsies can be prevented, and overdiagnosis of indolent cancers can...
Read More

New publication: Neurogenic bowel dysfunction score in spinal cord-injured patients: translation and validation of the Dutch-language NBD score

Abstract  Study design: This is a prospective validation study. Objectives: The neurogenic bowel dysfunction (NBD) score is a widely used symptom-based questionnaire...
Read More

New publication: Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

Abstract Background Guidelines recommend neoadjuvant chemotherapy (NAC) for the treatment of nonmetastatic muscle-invasive bladder cancer (MIBC). NAC is, however, underutilized in practice...
Read More

Research topics Erasmus MC urothelial cancer research group

Presentation Bladder Cancer Joost Boormans - YouTube  The Erasmus MC Urothelial Cancer Research Group conducts research into the molecular biology...
Read More

Europe’s Beating Cancer Plan brings hope for better prostate cancer outcomes [1]

In February 2021, on the eve of world cancer day, the European Commission presented its Europe’s Beating Cancer Plan, which...
Read More

New publication: Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

Abstract   Background: The optimal interval for repeat biopsy during active surveillance (AS) for prostate cancer is yet to be...
Read More

Waarom hebben mannen steeds slechter zaad?

De vruchtbaarheid van mannen neemt af. Hoe kan dat? In dit college van de Universiteit van Nederland vertelt uroloog Marij...
Read More

 

The full archive can be found by clicking here